Andrew C W Zannettino Selected Research

human TNFSF10 protein

9/2017

Anticancer efficacy of the hypoxia-activated prodrug evofosfamide is enhanced in combination with proapoptotic receptor agonists against osteosarcoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrew C W Zannettino Research Topics

Disease

21	Neoplasms (Cancer) 01/2024 - 01/2004
21	Multiple Myeloma 01/2024 - 09/2003
8	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2013 - 04/2005
6	Bone Diseases (Bone Disease) 07/2017 - 01/2004
5	Insulin Resistance 05/2021 - 08/2010
5	Osteosarcoma (Osteogenic Sarcoma) 09/2017 - 01/2004
5	Bone Resorption 01/2017 - 01/2004
5	Breast Neoplasms (Breast Cancer) 03/2016 - 10/2009
4	Hypoxia (Hypoxemia) 09/2017 - 05/2010
4	Fibrosis (Cirrhosis) 10/2011 - 09/2010
4	Osteolysis 01/2010 - 12/2006
3	Obesity 05/2021 - 05/2018
3	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2013 - 04/2005
2	Femoral Fractures (Femoral Fracture) 01/2020 - 04/2013
2	Osteoporosis 01/2018 - 06/2006
2	Craniosynostoses (Craniosynostosis) 01/2018 - 12/2016
2	Neoplasm Metastasis (Metastasis) 09/2017 - 02/2015
2	Myocardial Infarction 04/2014 - 05/2013
2	Salter-Harris Fractures 05/2012 - 05/2009
2	Hypophosphatemia 01/2010 - 03/2008
1	Mucositis 10/2023
1	Surgical Wound Infection 12/2022
1	Weight Loss (Weight Reduction) 01/2022
1	Thinness 02/2021
1	Overnutrition 02/2021
1	Weight Gain 02/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Carcinogenesis 01/2021
1	Genetic Translocation (Chromosomal Translocation) 10/2020
1	Musculoskeletal Abnormalities 01/2020
1	LEOPARD Syndrome (Syndrome, LEOPARD) 01/2020
1	Acrocephalosyndactylia (Apert Syndrome) 01/2018
1	Inflammation (Inflammations) 01/2017

Drug/Important Bio-Agent (IBA)

12	Imatinib Mesylate (Gleevec)FDA Link 01/2013 - 04/2005
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 09/2003
6	LigandsIBA 12/2016 - 03/2009
4	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2018
4	Mechanistic Target of Rapamycin Complex 1IBA 05/2021 - 01/2018
4	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2015 - 11/2008
4	Tyrosine Kinase InhibitorsIBA 01/2013 - 04/2005
3	Bortezomib (Velcade)FDA Link 01/2024 - 07/2017
3	Chemokine ReceptorsIBA 01/2024 - 10/2017
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2023 - 01/2013
3	AdiponectinIBA 01/2022 - 08/2010
3	Insulin (Novolin)FDA Link 05/2021 - 01/2018
3	Cadherins (E-Cadherin)IBA 06/2020 - 05/2013
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2018 - 04/2013
3	ProdrugsIBA 09/2017 - 02/2015
3	TH 302IBA 09/2017 - 02/2015
3	OsteoprotegerinIBA 08/2014 - 03/2009
3	Messenger RNA (mRNA)IBA 02/2011 - 09/2003
2	Peroxidase (Myeloperoxidase)IBA 11/2023 - 01/2017
2	LipidsIBA 02/2021 - 01/2013
2	Neutralizing AntibodiesIBA 08/2020 - 03/2011
2	DNA (Deoxyribonucleic Acid)IBA 09/2017 - 02/2015
2	drozitumabIBA 09/2017 - 12/2014
2	dactolisibIBA 04/2015 - 10/2010
2	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 08/2014 - 03/2011
2	Conditioned Culture MediaIBA 10/2011 - 12/2006
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2011 - 03/2009
2	Chemokine CXCL12IBA 05/2010 - 12/2006
2	Phosphates (Orthophosphate)IBA 01/2010 - 03/2008
2	CalciumIBA 01/2010 - 03/2008
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 05/2009 - 04/2005
1	Proteasome InhibitorsIBA 01/2024
1	Medical MarijuanaIBA 10/2023
1	CytokinesIBA 01/2023
1	Peptide Hydrolases (Proteases)FDA Link 01/2023
1	Liposomes (Liposome)IBA 12/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2022
1	HydrogelsIBA 12/2022
1	ChitosanIBA 12/2022
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 01/2021
1	Eukaryotic Initiation Factor-4EIBA 01/2021
1	Histone MethyltransferasesIBA 10/2020
1	Immunoglobulin G (IgG)IBA 08/2020
1	Peptides (Polypeptides)IBA 06/2020
1	Immunoglobulins (Immunoglobulin)IBA 01/2020
1	Fibronectins (Fibronectin)IBA 01/2020
1	Ephrin-B1 (Ephrin B1)IBA 01/2020
1	Protein Tyrosine PhosphatasesIBA 01/2020
1	OsteopontinIBA 05/2018
1	OsteocalcinIBA 01/2018
1	Blood Glucose (Blood Sugar)IBA 01/2018
1	SecretagoguesIBA 01/2018
1	Testosterone (Sustanon)FDA Link 01/2018
1	CrizotinibIBA 01/2018
1	azomycinIBA 09/2017
1	isophosphamide mustard (IPAM)IBA 09/2017
1	human TNFSF10 proteinIBA 09/2017
1	PhosphatidylserinesIBA 01/2017
1	EnzymesIBA 01/2017
1	RANK LigandIBA 01/2017

Therapy/Procedure

14	Therapeutics 01/2024 - 06/2006
3	Drug Therapy (Chemotherapy) 01/2024 - 12/2014
3	Cell Transplantation 09/2017 - 03/2009
2	Treatment Delay 05/2013 - 10/2009
1	Caloric Restriction 05/2021
1	Ovariectomy (Oophorectomy) 01/2018
1	Sutures (Suture) 01/2018